EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische Studie

Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809)

Takahiro Kinoshita, Masayuki Yokoyama, Junya Kitadani, Takeshi Omori, Souya Nunobe, Shinji Kuroda, Michitaka Honda, Haruhiko Cho, Masaki Aizawa, Yukinori Kurokawa, Tomoya Tsukada, Shusuke Haruta und 5 weitere

Gastric Cancer · 2026-11 · 29 (6) · 1372-1383

DOI: 10.1007/s10120-026-01792-1 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Gastric Cancer, online erschienen am 24.08.2026. Verfasst von Takahiro Kinoshita und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, 277-8577, Japan. takkinos@east.ncc.go.jp. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Laparoscopy, Robotic Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Advanced proximal gastric cancer (APGC) involving the greater curvature (Gre) sometimes metastasized to the splenic hilar lymph node (No.10 LN), so total gastrectomy with splenectomy has been the standard treatment aiming for complete removal of it; however, the high incidence of complications has been problematic. METHODS: We conducted a multicenter phase-II trial to assess the safety and efficacy of laparoscopic or robotic spleen preserving splenic hilar dissection (LR-SHD) which has the potential to reduce complications. Eligibility criteria included cT2-4a resectable APGC involving the Gre without obvious No.10 metastasis. Macroscopic type 4 and large type 3 (≥ 8 cm) were excluded. LR-SHD with total gastrectomy (D2+No.10) was performed by qualified surgeons. The primary endpoint was the proportion of postoperative pancreatic fistula and/or intra-abdominal abscess (Grade ≥ III). The sample size was 85 considering a threshold of 16% and one-sided alpha of 0.1. RESULTS: Between August 2019 and December 2024, 85 eligible patients (cT2/T3/T4a = 32/38/15) were enrolled, and resection was performed in 81. The median operation time was 379 min, and the median blood loss was 30 ml. No.10 metastasis was observed in 12.5% (10/80). Overall complications (Grade ≥ III) occurred in 9.9% (8/81). Pancreatic fistula and/or intra-abdominal abscess occurred in 1.2% (1/81; 80% confidence interval: 0.1-4.7%), which was significantly lower than prespecified threshold (one-sided p < 0.0001). No treatment-related mortality occurred. CONCLUSIONS: This study confirmed the safety and feasibility of LR-SHD when performed by experienced surgeons. This procedure is highly promising for treating APGC with the Gre invasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGastrectomyLaparoscopyRobotic Surgical ProceduresOrgan Sparing TreatmentsHumansFemaleMaleMiddle AgedAgedLymph Node ExcisionPostoperative ComplicationsSpleenAdult

Stichwörter der Autor:innen

Advanced gastric cancerLaparoscopic gastrectomyRobotic gastrectomySplenic hilar lymph node dissection

Autor:innen und Institutionen

  • Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, 277-8577, Japan. takkinos@east.ncc.go.jp.
  • Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
  • Department of Gastroenterological Surgery, Osaka International Cancer Institute, , Osaka, Japan.
  • Department of Gastric Surgery, Cancer Institute Hospital, Tokyo, Japan.
  • Department of Gastroenterological Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Zitieren

APA

Kinoshita, T., Yokoyama, M., Kitadani, J., Omori, T., Nunobe, S., Kuroda, S., Honda, M., Cho, H., Aizawa, M., Kurokawa, Y., Tsukada, T., Haruta, S., Misawa, K., Ehara, K., Kawabata, K., Terashima, M., & Yoshikawa, T. (2026). Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809). Gastric Cancer, 29(6), 1372-1383. https://doi.org/10.1007/s10120-026-01792-1

Vancouver

Kinoshita T, Yokoyama M, Kitadani J, Omori T, Nunobe S, Kuroda S, et al. Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809). Gastric Cancer. 2026;29(6):1372-1383. doi:10.1007/s10120-026-01792-1

BibTeX
@article{Kinoshita2026,
  author = {Kinoshita, Takahiro and Yokoyama, Masayuki and Kitadani, Junya and Omori, Takeshi and Nunobe, Souya and Kuroda, Shinji and Honda, Michitaka and Cho, Haruhiko and Aizawa, Masaki and Kurokawa, Yukinori and Tsukada, Tomoya and Haruta, Shusuke and Misawa, Kazunari and Ehara, Kazuhisa and Kawabata, Kota and Terashima, Masanori and Yoshikawa, Takaki},
  title = {Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809)},
  journal = {Gastric Cancer},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {1372--1383},
  doi = {10.1007/s10120-026-01792-1}
}
Kostenlos starten →